The Lancet Respiratory Medicine in conversation with
En podkast av The Lancet Group
156 Episoder
-
Tuberculosis and the microbiome
Publisert: 3.9.2019 -
Antibiotics and non-severe exacerbations of bronchiectasis in children
Publisert: 16.8.2019 -
Use of extended-criteria donors for lung transplantation
Publisert: 6.8.2019 -
α1-antitrypsin deficiency testing
Publisert: 30.7.2019 -
Live-attenuated influenza vaccines in children
Publisert: 24.6.2019 -
Clearing the air on ambient air pollution
Publisert: 19.6.2019 -
A second look at FEAST
Publisert: 12.6.2019 -
Intensive care units and the USA
Publisert: 21.5.2019 -
A respiratory family affair
Publisert: 17.4.2019 -
A global approach to children's asthma
Publisert: 22.2.2019 -
The effectiveness of pleural manometry
Publisert: 14.2.2019 -
Lung volume reduction and emphysema
Publisert: 8.2.2019 -
Glimmers of hope for MDR-Tuberculosis treatment
Publisert: 8.1.2019 -
Effectiveness of flu vaccine over time
Publisert: 16.11.2018 -
Towards an International Pneumonia Network
Publisert: 12.11.2018 -
Laparoscopic anti-reflux surgery and IPF
Publisert: 2.11.2018 -
Improving the lives of patients with bronchiectasis
Publisert: 20.9.2018 -
Deep learning and fibrotic lung disease
Publisert: 17.9.2018 -
Critical care and infant nutrition
Publisert: 15.9.2018 -
Precision medicine in ARDS
Publisert: 3.8.2018
Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.
